Letter to the U.S. House of Representatives Opposing Senate Bill That Would Provide False Hope to Seriously Ill Patients

September 5, 2017

View as PDF.

Public Citizen and 16 other groups sent a letter to members of the U.S. House of Representatives urging them to oppose S. 204, which is deceptively titled the “Right to Try Act of 2017” but should instead be called the “False Hope Act of 2017.”  The legislation, as amended and passed by the U.S. Senate on August 3, 2017, would put countless patients at risk by undermining important FDA safety rules related to the use and oversight of unapproved, experimental medications.